CN104447570A - Synthesis method for 5-bromo-2-fluoropyrimidine - Google Patents
Synthesis method for 5-bromo-2-fluoropyrimidine Download PDFInfo
- Publication number
- CN104447570A CN104447570A CN201410631464.2A CN201410631464A CN104447570A CN 104447570 A CN104447570 A CN 104447570A CN 201410631464 A CN201410631464 A CN 201410631464A CN 104447570 A CN104447570 A CN 104447570A
- Authority
- CN
- China
- Prior art keywords
- bromo
- suction filtration
- cooled
- methylene dichloride
- ice
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/30—Halogen atoms or nitro radicals
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The invention discloses a synthesis method for 5-bromo-2-fluoropyrimidine. The synthesis method comprises the following steps: dissolving 2-hydroxypyrimidine salt as a raw material through deionized water, and regulating the pH to 6 with saturated sodium bicarbonate solution, so as to prepare 2-hydroxypyrimidine; enabling bromine to react with 2-hydroxypyrimidine below 5 DEG C, and preparing 2-hydroxy-5-bromopyrimidine through methyl alcohol recrystallization; carrying out temperature control reaction on 2-hydroxy-5-bromopyrimidine, POCl3 and triethylamine for 8 hours; and cooling to room temperature, reacting with fluorine, carrying out suction filtration under adjustment of a sodium hydroxide solution, washing, drying and carrying out chromatography, so as to obtain white solid, wherein the yield can reach over 91%.
Description
Technical field
The present invention relates to a kind of synthetic method of compound, the synthetic method of the bromo-2-5-FU of a kind of 5-.
Background technology
Pyrimidines causes the extensive concern of people as the elementary cell of new drug molecular designing and synthesis, pyrimidines is widely used in the preparation of agricultural chemicals and medicine at present, synthesis agrochemicals weedicides, the intermediate of the medicines such as medical pain killer and dyestuff.5-halogenated pyrimidine derivative has chemotherapy significantly because of it, biological chemistry isoreactivity, has synthesized the nucleoside analog in a large number with physiologically active have vast potential for future development as pharmaceutical intermediate in pharmaceutical industry and genetically engineered.As; 5 FU 5 fluorouracil is applied to clinical as good cancer therapy drug, and 5-bromo pyrimi piperidine liquid is used to inflammatory cells etc.
Summary of the invention
The invention provides a kind ofly to consume less, the synthetic method of cheaper starting materials is easy to get, yield the is high bromo-2-5-FU of 5-.
For achieving the above object, the synthetic route of the bromo-2-5-FU of 5-of the present invention is:
The building-up process of the bromo-2-5-FU of the 5-that the present invention relates to comprises the following steps:
1, the synthesis of 2-hydroxy pyrimidine
(1) by 23g2-hydroxy pyrimidine salt 100mL deionized water dissolving, ice-water bath degraded is to less than 0 DEG C, and dripping saturated sodium bicarbonate aqueous solution adjust pH is 6, and temperature control less than 0 DEG C continues to stir 20min;
(2) use 100mL dichloromethane extraction 3 times, merge organic phase, 25mL saturated salt washes three times, adds 0.5g gac, anhydrous sodium sulfate drying, suction filtration, and 30mL methylene dichloride divides 3 washing leaching cakes, and evaporate to dryness methylene dichloride, obtains white solid.
2, the synthesis of 2-hydroxyl-5-bromo pyrimi piperidine
1) in the deionized water of 250mL, add 35g2-hydroxy pyrimidine, ice-water bath is cooled to less than 5 DEG C, slowly adds 40g bromine;
(2) rise to room temperature, continue to stir 45min, suction filtration, be washed to filtrate and become neutral, anhydrous magnesium sulfate drying, steams solvent, residue on neutral alumina column chromatography for separation, then uses 52g white powder solid after the ethyl alcohol recrystallization of 20mL85%.
3, the synthesis of the bromo-2-5-FU of 5-
(1) in reaction flask, 8g2-hydroxyl-5-bromo pyrimi piperidine is added, 70mLPOCl
3, slowly drip 3.2g triethylamine, be warming up to backflow, temperature control reaction 8h, reclaims POCl
350mL;
(2) be cooled to room temperature, add methylene dichloride 30mL wherein and pour trash ice into, being cooled to-8 DEG C, drip the fluorine 30g that massfraction is 50%, insulation 4-5h;
(3) adjust pH=7, suction filtration, washing with the aqueous sodium hydroxide solution that 20mL massfraction is 10%, dry, steaming desolventizes, residue by silicagel column chromatography, and obtain white solid 9.2g, yield reaches 91%.
Specific embodiments
The building-up process of the bromo-2-5-FU of a kind of 5-that the present invention relates to comprises the following steps:
By 23g2-hydroxy pyrimidine salt 100mL deionized water dissolving, ice-water bath degraded is to less than 0 DEG C, and dripping saturated sodium bicarbonate aqueous solution adjust pH is 6, and temperature control less than 0 DEG C continues to stir 20min; With 100mL dichloromethane extraction 3 times, merge organic phase, 25mL saturated salt washes three times, adds 0.5g gac, anhydrous sodium sulfate drying, suction filtration, and 30mL methylene dichloride divides 3 washing leaching cakes, and evaporate to dryness methylene dichloride, obtains white solid.In the deionized water of 250mL, add 35g2-hydroxy pyrimidine, ice-water bath is cooled to less than 5 DEG C, slowly adds 40g bromine; Rise to room temperature, continue to stir 45min, suction filtration, be washed to filtrate and become neutral, anhydrous magnesium sulfate drying, steams solvent, residue on neutral alumina column chromatography for separation, then uses 52g white powder solid after the ethyl alcohol recrystallization of 20mL85%.8g2-hydroxyl-5-bromo pyrimi piperidine is added, 70mLPOCl in reaction flask
3, slowly drip 3.2g triethylamine, be warming up to backflow, temperature control reaction 8h, reclaims POCl
350mL; Be cooled to room temperature, add methylene dichloride 30mL wherein and pour trash ice into, being cooled to-8 DEG C, drip the fluorine 30g that massfraction is 50%, insulation 4-5h; Adjust pH=7, suction filtration with the aqueous sodium hydroxide solution that 20mL massfraction is 10%, washing, dry, steaming desolventizes, residue by silicagel column chromatography, obtains white solid 9.2g, calculated yield.
Example 1
By 23g2-hydroxy pyrimidine salt 100mL deionized water dissolving, ice-water bath degraded is to less than 0 DEG C, and dripping saturated sodium bicarbonate aqueous solution adjust pH is 6, and temperature control less than 0 DEG C continues to stir 20min; With 100mL dichloromethane extraction 3 times, merge organic phase, 25mL saturated salt washes three times, adds 0.5g gac, anhydrous sodium sulfate drying, suction filtration, and 30mL methylene dichloride divides 3 washing leaching cakes, and evaporate to dryness methylene dichloride, obtains white solid.In the deionized water of 250mL, add 35g2-hydroxy pyrimidine, ice-water bath is cooled to less than 5 DEG C, slowly adds 40g bromine; Rise to room temperature, continue to stir 45min, suction filtration, be washed to filtrate and become neutral, anhydrous magnesium sulfate drying, steams solvent, residue on neutral alumina column chromatography for separation, then uses 52g white powder solid after the ethyl alcohol recrystallization of 20mL85%.8g2-hydroxyl-5-bromo pyrimi piperidine is added, 70mLPOCl in reaction flask
3, slowly drip 3.2g triethylamine, be warming up to backflow, temperature control reaction 8h, reclaims POCl
350mL; Be cooled to room temperature, add methylene dichloride 30mL wherein and pour trash ice into, being cooled to-8 DEG C, drip the fluorine 30g that massfraction is 50%, insulation 4h; Adjust pH=7, suction filtration with the aqueous sodium hydroxide solution that 20mL massfraction is 10%, washing, dry, steaming desolventizes, residue by silicagel column chromatography, and obtain white solid 9.2g, yield reaches more than 91%.
Example 2
By 23g2-hydroxy pyrimidine salt 100mL deionized water dissolving, ice-water bath degraded is to less than 0 DEG C, and dripping saturated sodium bicarbonate aqueous solution adjust pH is 6, and temperature control less than 0 DEG C continues to stir 20min; With 100mL dichloromethane extraction 3 times, merge organic phase, 25mL saturated salt washes three times, adds 0.5g gac, anhydrous sodium sulfate drying, suction filtration, and 30mL methylene dichloride divides 3 washing leaching cakes, and evaporate to dryness methylene dichloride, obtains white solid.In the deionized water of 250mL, add 35g2-hydroxy pyrimidine, ice-water bath is cooled to less than 5 DEG C, slowly adds 40g bromine; Rise to room temperature, continue to stir 45min, suction filtration, be washed to filtrate and become neutral, anhydrous magnesium sulfate drying, steams solvent, residue on neutral alumina column chromatography for separation, then uses 52g white powder solid after the ethyl alcohol recrystallization of 20mL85%.8g2-hydroxyl-5-bromo pyrimi piperidine is added, 70mLPOCl in reaction flask
3, slowly drip 3.2g triethylamine, be warming up to backflow, temperature control reaction 8h, reclaims POCl
350mL; Be cooled to room temperature, add methylene dichloride 30mL wherein and pour trash ice into, being cooled to-8 DEG C, drip the fluorine 30g that massfraction is 50%, insulation 4.5h; Adjust pH=7, suction filtration with the aqueous sodium hydroxide solution that 20mL massfraction is 10%, washing, dry, steaming desolventizes, residue by silicagel column chromatography, and obtain white solid 9.2g, yield reaches more than 91%.
Example 3
By 23g2-hydroxy pyrimidine salt 100mL deionized water dissolving, ice-water bath degraded is to less than 0 DEG C, and dripping saturated sodium bicarbonate aqueous solution adjust pH is 6, and temperature control less than 0 DEG C continues to stir 20min; With 100mL dichloromethane extraction 3 times, merge organic phase, 25mL saturated salt washes three times, adds 0.5g gac, anhydrous sodium sulfate drying, suction filtration, and 30mL methylene dichloride divides 3 washing leaching cakes, and evaporate to dryness methylene dichloride, obtains white solid.In the deionized water of 250mL, add 35g2-hydroxy pyrimidine, ice-water bath is cooled to less than 5 DEG C, slowly adds 40g bromine; Rise to room temperature, continue to stir 45min, suction filtration, be washed to filtrate and become neutral, anhydrous magnesium sulfate drying, steams solvent, residue on neutral alumina column chromatography for separation, then uses 52g white powder solid after the ethyl alcohol recrystallization of 20mL85%.8g2-hydroxyl-5-bromo pyrimi piperidine is added, 70mLPOCl in reaction flask
3, slowly drip 3.2g triethylamine, be warming up to backflow, temperature control reaction 8h, reclaims POCl
350mL; Be cooled to room temperature, add methylene dichloride 30mL wherein and pour trash ice into, being cooled to-8 DEG C, drip the fluorine 30g that massfraction is 50%, insulation 5h; Adjust pH=7, suction filtration with the aqueous sodium hydroxide solution that 20mL massfraction is 10%, washing, dry, steaming desolventizes, residue by silicagel column chromatography, and obtain white solid 9.2g, yield reaches more than 91%.
Claims (3)
1. a synthetic method for the bromo-2-5-FU of 5-, is characterized in that the synthesis of 2-hydroxy pyrimidine:
(1) by 23g2-hydroxy pyrimidine salt 100mL deionized water dissolving, ice-water bath degraded is to less than 0 DEG C, and dripping saturated sodium bicarbonate aqueous solution adjust pH is 6, and temperature control less than 0 DEG C continues to stir 20min;
(2) use 100mL dichloromethane extraction 3 times, merge organic phase, 25mL saturated salt washes three times, adds 0.5g gac, anhydrous sodium sulfate drying, suction filtration, and 30mL methylene dichloride divides 3 washing leaching cakes, and evaporate to dryness methylene dichloride, obtains white solid.
2. the synthetic method of the bromo-2-5-FU of a kind of 5-according to claim 1, is characterized in that the synthesis of 2-hydroxyl-5-bromo pyrimi piperidine:
(1) in the deionized water of 250mL, add 35g2-hydroxy pyrimidine, ice-water bath is cooled to less than 5 DEG C, slowly adds 40g bromine;
(2) rise to room temperature, continue to stir 45min, suction filtration, be washed to filtrate and become neutral, anhydrous magnesium sulfate drying, steams solvent, residue on neutral alumina column chromatography for separation, then uses 52g white powder solid after the ethyl alcohol recrystallization of 20mL85%.
3. the synthetic method of the bromo-2-5-FU of a kind of 5-according to claim 1, is characterized in that:
(1) in reaction flask, 8g2-hydroxyl-5-bromo pyrimi piperidine is added, 70mLPOCl
3, slowly drip 3.2g triethylamine, be warming up to backflow, temperature control reaction 8h, reclaims POCl
350mL;
(2) be cooled to room temperature, add methylene dichloride 30mL wherein and pour trash ice into, being cooled to-8 DEG C, drip the fluorine 30g that massfraction is 50%, insulation 4-5h;
(3) adjust pH=7, suction filtration, washing with the aqueous sodium hydroxide solution that 20mL massfraction is 10%, dry, steaming desolventizes, residue by silicagel column chromatography, and obtain white solid 9.2g, yield reaches 91%.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410631464.2A CN104447570A (en) | 2014-11-11 | 2014-11-11 | Synthesis method for 5-bromo-2-fluoropyrimidine |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410631464.2A CN104447570A (en) | 2014-11-11 | 2014-11-11 | Synthesis method for 5-bromo-2-fluoropyrimidine |
Publications (1)
Publication Number | Publication Date |
---|---|
CN104447570A true CN104447570A (en) | 2015-03-25 |
Family
ID=52894399
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201410631464.2A Pending CN104447570A (en) | 2014-11-11 | 2014-11-11 | Synthesis method for 5-bromo-2-fluoropyrimidine |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN104447570A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN114591250A (en) * | 2022-03-19 | 2022-06-07 | 杭州布朗生物医药科技有限公司 | One-step synthesis method of 5-bromo-2-chloropyrimidine |
-
2014
- 2014-11-11 CN CN201410631464.2A patent/CN104447570A/en active Pending
Non-Patent Citations (4)
Title |
---|
BARAM, S. G.等: "Pyrimidines. IX. Synthesis of 5-substituted 2-fluoropyrimidines", 《IZVESTIYA SIBIRSKOGO OTDELENIYA AKADEMII NAUK SSSR》 * |
IVANOVSKAYA, L. YU.等: "Mass spectra of pyrimidine derivatives. IV. Disubstituted halogen-containing pyrimidines", 《IZVESTIYA SIBIRSKOGO OTDELENIYA AKADEMII NAUK SSSR》 * |
TEPPEI FUJIMOTO等: "PhenoFluor: Practical Synthesis, New Formulation, and Deoxyfluorination of Heteroaromatics", 《ORG. PROCESS RES. DEV.》 * |
陈建兵等: "2-碘-5-溴嘧啶的合成", 《池州学院学报》 * |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN114591250A (en) * | 2022-03-19 | 2022-06-07 | 杭州布朗生物医药科技有限公司 | One-step synthesis method of 5-bromo-2-chloropyrimidine |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103524440B (en) | The preparation method of gout therapertics Lesinurad and Lesinurad intermediate | |
CN103896855B (en) | The synthetic method of the fluoro-6-chlorine of a kind of 4-(1-bromoethyl)-5-pyrimidine | |
CN105566215A (en) | Preparation method of Stivarga | |
CN104277000A (en) | Abscisic acid receptor stimulant raw drug and preparation method thereof | |
CN102167716A (en) | Synthesis method of clofarabine, midbody thereof and preparation method of midbody | |
CN104447570A (en) | Synthesis method for 5-bromo-2-fluoropyrimidine | |
CN104086463B (en) | The preparation method of a kind of Isosorbide-5-Nitrae-Ding disulfonic acid fine work and solution thereof | |
CN103772189B (en) | Synthesis method of diethylstilbestrol compound methyl pigeon pea ketonic acid A | |
CN102924473B (en) | The preparation method of the chloro-7-iodothiophen of a kind of 2-also [3,2-D] pyrimidine | |
CN108440623A (en) | A kind of preparation method and products thereof of capecitabine intermediate | |
CN104557877B (en) | A kind of avanaphil intermediate and its preparation method and application | |
CN103351346A (en) | Preparation method of impurity HP1 in bendamustine hydrochloride | |
CN105085267A (en) | Synthetic method for salvianolic acid A | |
CN107382877A (en) | A kind of synthetic method of 4 amino 2 methyl 5 (bromomethyl) pyrimidine hydrobromate | |
CN104447724B (en) | A kind of process for purification of Raltitrexed | |
CN103588758A (en) | Synthesis and preparation of nitroimidazole derivative containing 1,4-benzdioxan skeleton and application of nitroimidazole derivative in anticancer drugs | |
CN104434928B (en) | The application in preparing anti-hepatic fibrosis medicines of O-(piperazinyl) ethyl derivative of Cleistanone | |
CN104761599A (en) | Preparation method of 5,4'-dihydroxy flavone-7-O-D-glucuronic acid | |
CN106588690B (en) | The preparation method of Holotrichia trichophora A prime Abrusamide | |
CN104892565A (en) | Artificial synthesis method of neomarchantin A | |
CN104650160A (en) | Novel synthesis method of capecitabine key intermediate 1,2,3-O-triacetyl-5-deoxy-D-ribose | |
CN102584709A (en) | Improved process for preparing aryl imidazole aldehyde serving as eprosartan intermediate | |
CN104262450A (en) | Method for preparing and refining eplerenone | |
CN101481399A (en) | Method for synthesizing positive electron radioactive imaging agent labeled precursor thymidine derivative | |
CN103351347A (en) | Preparation method of impurity DCE in bendamustine hydrochloride |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20150325 |